Cerebral histoplasmosis in an Australian patient with systemic lupus erythematosus.
A 39-year-old woman with systemic lupus erythematosus suffered a prolonged neurological illness associated with very low levels of glucose in her cerebrospinal fluid (CSF). Six months later, and after numerous CSF investigations, Histoplasma capsulatum was cultured. To our knowledge, this is the first report of cerebral histoplasmosis in Australia in a patient who is not HIV positive.
Sullivan
A A
AA
Princess Alexandra Hospital, Brisbane, QLD.
Benson
S M
SM
Ewart
A H
AH
Hogan
P G
PG
Whitby
R M
RM
Boyle
R S
RS
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D001786:Blood Glucose / Q000378:metabolism; D001921:Brain / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D006660:Histoplasmosis / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D016921:Meningitis, Fungal / Q000175:diagnosis* / Q000188:drug therapy; D009460:Neurologic Examination; D009894:Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy
D000935:Antifungal Agents; D001786:Blood Glucose; D017964:Itraconazole; D000666:Amphotericin B